Position in BNTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,457,196
+$4,770,519 QoQ
Shares Held
58,648
+713.1% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#79
of 282 holders
Holding Since
Jun 2022
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026HRT FINANCIAL LP holds $848,572,765 across 183 Biotechnology names. BNTX ranks #37 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
1,089,376 | $81,136,724 | |
| 2 | INSM |
INSMED Inc
|
689,981 | $73,565,774 | |
| 3 | EXEL |
Exelixis, Inc.
|
929,242 | $50,560,057 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
84,634 | $45,444,226 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
178,491 | $43,689,242 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
498,655 | $40,645,369 | |
| 7 | ABVX |
Abivax S.A.
|
270,612 | $36,061,755 | |
| 8 | TGTX |
Tg Therapeutics, Inc.
|
622,603 | $34,205,808 |
All Filings in BNTX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,457,196 | 58,648 | Shares | Defined | 2026-08-14 | |
| 2025-12-31 | $686,677 | 7,213 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $3,641,149 | 36,921 | Shares | Defined | 2025-11-14 | |
| 2024-12-31 | $464,232 | 4,074 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $380,182 | 3,201 | Shares | Defined | 2024-11-12 | |
| 2023-12-31 | $375,300 | 3,556 | Shares | Defined | 2024-02-09 | |
| 2022-06-30 | $577,613 | 3,874 | Shares | Defined | 2022-08-12 | |
| No filing history on record for this holder in this stock. | ||||||